You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Haloperidol - Generic Drug Details

✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for haloperidol and what is the scope of patent protection?

Haloperidol is the generic ingredient in six branded drugs marketed by Ortho Mcneil, Ortho Mcneil Pharm, Actavis Group, Aiping Pharm Inc, Chartwell Rx, Duramed Pharms Barr, Innogenix, Lederle, MSN, Mylan, Par Pharm, Purepac Pharm, Quantum Pharmics, Royce Labs, Sciegen Pharms Inc, SCS, Strides Pharma, Upsher Smith Labs, Watson Labs, Zydus Pharms Usa, Janssen Pharms, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma, Hospira, Mankind Pharma, Meitheal, Mylan Labs Ltd, Sandoz, Somerset Theraps Llc, Teva Pharms Usa, Zydus Pharms, Alpharma, Lannett Co Inc, Morton Grove, Pharm Assoc, Rubicon, Teva, Teva Pharms, Abraxis Pharm, Baxter Hlthcare Corp, Epic Pharma Llc, Fosun Pharma, Marsam Pharms Llc, Sagent Pharms, Smith And Nephew, Solopak, and Actavis Mid Atlantic, and is included in one hundred and twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for haloperidol. Twenty-one suppliers are listed for this compound.

Summary for haloperidol

US Patents:	0
Tradenames:	6
Applicants:	48
NDAs:	112
Drug Master File Entries:	20
Finished Product Suppliers / Packagers:	21
Raw Ingredient (Bulk) Api Vendors:	139
Clinical Trials:	217
Patent Applications:	6,796
Formulation / Manufacturing:	see details
Drug Prices:	Drug price trends for haloperidol
Drug Sales Revenues:	Drug sales revenues for haloperidol
What excipients (inactive ingredients) are in haloperidol?	haloperidol excipients list
DailyMed Link:	haloperidol at DailyMed

See drug prices for haloperidol

Drug Sales Revenue Trends for haloperidol

See drug sales revenues for haloperidol

Recent Clinical Trials for haloperidol

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Christian Hassager	Phase 3
Qilu Pharmaceutical Co., Ltd.	Phase 3
Cancer Prevention Research Institute of Texas	Phase 2/Phase 3

See all haloperidol clinical trials

Pharmacology for haloperidol

Drug Class	Typical Antipsychotic

Medical Subject Heading (MeSH) Categories for haloperidol

Anti-Dyskinesia Agents
Antiemetics
Antipsychotic Agents
Dopamine Antagonists

US Patents and Regulatory Information for haloperidol

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Gland Pharma Ltd	HALOPERIDOL	haloperidol lactate	INJECTABLE;INJECTION	076774-001	Aug 25, 2004	AP	RX	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Quantum Pharmics	HALOPERIDOL	haloperidol	TABLET;ORAL	071255-001	Feb 17, 1987		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Quantum Pharmics	HALOPERIDOL	haloperidol	TABLET;ORAL	071257-001	Feb 17, 1987		DISCN	No	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for haloperidol

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ortho Mcneil	HALDOL	haloperidol	TABLET;ORAL	015921-003	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Ortho Mcneil	HALDOL	haloperidol	TABLET;ORAL	015921-004	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Ortho Mcneil	HALDOL	haloperidol	TABLET;ORAL	015921-005	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.